conv.

All stories
BusinessFading · day 3

Novo CEO pledges to fill strategic gaps through outside partnerships

Mike Doustdar tells Bloomberg the drugmaker must look beyond its own portfolio to build investor confidence.

newest coverage 2h agosummary written 1d ago5 pieces YouTubeNewswiresGoogle News

What to know

  • Novo CEO acknowledges the company needs to do more to win back investor confidence.
  • Doustdar signals openness to external partnerships and innovation rather than relying solely on internal development.
  • The strategy applies specifically to Novo's expansion of obesity drug offerings, where gaps exist.

Mike DoustdarMike Doustdar Novo CEONovo Pharmaceutical company

How it unfolded 1 development · click the chart to see its coverage articlesvideos

Peak 2 pieces in one hour at Sep 22, 2 AM; 5 pieces over 3 days (4 articles · 1 video) Sep 21, 10 AM — 1 piece · 1 article — Google News 1Sep 21, 11 AM — quietSep 21, 12 PM — quietSep 21, 1 PM — quietSep 21, 2 PM — quietSep 21, 3 PM — quietSep 21, 4 PM — quietSep 21, 5 PM — quietSep 21, 6 PM — quietSep 21, 7 PM — quietSep 21, 8 PM — quietSep 21, 9 PM — quietSep 21, 10 PM — quietSep 21, 11 PM — quietSep 22, 12 AM — quietSep 22, 1 AM — quietSep 22, 2 AM — 2 pieces · 1 article · 1 video — Newswires 1, YouTube 1Sep 22, 3 AM — quietSep 22, 4 AM — 1 piece · 1 article — Google News 1Sep 22, 5 AM — quietSep 22, 6 AM — quietSep 22, 7 AM — quietSep 22, 8 AM — quietSep 22, 9 AM — quietSep 22, 10 AM — quietSep 22, 11 AM — quietSep 22, 12 PM — quietSep 22, 1 PM — quietSep 22, 2 PM — quietSep 22, 3 PM — quietSep 22, 4 PM — quietSep 22, 5 PM — quietSep 22, 6 PM — quietSep 22, 7 PM — quietSep 22, 8 PM — quietSep 22, 9 PM — quietSep 22, 10 PM — quietSep 22, 11 PM — quietYesterday, 12 AM — quietYesterday, 1 AM — quietYesterday, 2 AM — quietYesterday, 3 AM — quietYesterday, 4 AM — quietYesterday, 5 AM — quietYesterday, 6 AM — quietYesterday, 7 AM — quietYesterday, 8 AM — quietYesterday, 9 AM — quietYesterday, 10 AM — quietYesterday, 11 AM — quietYesterday, 12 PM — quietYesterday, 1 PM — quietYesterday, 2 PM — quietYesterday, 3 PM — quietYesterday, 4 PM — quietYesterday, 5 PM — quietYesterday, 6 PM — quietYesterday, 7 PM — quietYesterday, 8 PM — quietYesterday, 9 PM — quietYesterday, 10 PM — quietYesterday, 11 PM — quietToday, 12 AM — quietToday, 1 AM — 1 piece · 1 article — Newswires 1Today, 2 AM — quietToday, 3 AM — quiet 1
Sep 22yesterdaynow · 4:43 AM ET
  1. 1

    Doustdar tells Bloomberg Novo will seek external innovation to fill gaps

    Novo CEO Mike Doustdar discussed investor confidence and drug testing in an interview with Bloomberg Television, signaling the company's willingness to look outside for strategic and scientific partnerships to expand its obesity offerings.

    “We should also have a mindset that we don't have a patent or a monopoly on all the good ideas. When there is a gap, strategically or scientifically, we're looking outside to see how we can fill the gaps.”
    — Mike Doustdar
    1. 2 outlets Novo CEO Says Drugmaker Has More to Do to Win Over Investors

      first by Bloomberg.com, 2d ago · also Endpoints News

      1 more headline